FR970M - - Google Patents

Info

Publication number
FR970M
FR970M FR837319A FR837319A FR970M FR 970 M FR970 M FR 970M FR 837319 A FR837319 A FR 837319A FR 837319 A FR837319 A FR 837319A FR 970 M FR970 M FR 970M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR837319A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR837319A priority Critical patent/FR970M/fr
Application granted granted Critical
Publication of FR970M publication Critical patent/FR970M/fr
Active legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
FR837319A 1958-11-04 1960-08-31 Active FR970M (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR837319A FR970M (fi) 1958-11-04 1960-08-31

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB35428/58A GB870286A (en) 1958-11-04 1958-11-04 Improvements in or relating to 6-methyl-3-oxo-í~-steroid compounds
FR809052A FR1333711A (fr) 1958-11-04 1959-11-02 Procédé de fabrication des 6-méthyl-3-oxo-delta4,6-stéroïdes
FR837319A FR970M (fi) 1958-11-04 1960-08-31

Publications (1)

Publication Number Publication Date
FR970M true FR970M (fi) 1961-12-04

Family

ID=10377599

Family Applications (2)

Application Number Title Priority Date Filing Date
FR809052A Expired FR1333711A (fr) 1958-11-04 1959-11-02 Procédé de fabrication des 6-méthyl-3-oxo-delta4,6-stéroïdes
FR837319A Active FR970M (fi) 1958-11-04 1960-08-31

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR809052A Expired FR1333711A (fr) 1958-11-04 1959-11-02 Procédé de fabrication des 6-méthyl-3-oxo-delta4,6-stéroïdes

Country Status (7)

Country Link
US (1) US3356573A (fi)
BE (1) BE584312A (fi)
CH (1) CH379493A (fi)
DE (1) DE1120446B (fi)
FR (2) FR1333711A (fi)
GB (1) GB870286A (fi)
MY (1) MY6400075A (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1210819B (de) * 1962-03-23 1966-02-17 Ayerst Mckenna & Harrison Verfahren zur Herstellung von in 17alpha-Stellung alkylierten Pregnanderivaten
DE1201342B (de) * 1963-03-05 1965-09-23 Olin Mathieson Verfahren zur Herstellung von Steroiden
US4370321A (en) * 1976-09-01 1983-01-25 Mead Johnson And Company Progestational adjuvant therapy
US4346037A (en) * 1981-07-10 1982-08-24 The Upjohn Company Base catalyzed acylation with enol esters
US5338732A (en) * 1991-06-18 1994-08-16 Bristol-Myers Squibb Company Megestrol acetate formulation
BR9908592A (pt) * 1998-03-11 2001-04-24 Endorech Inc Processo para inibir a atividade de 17ß-hidroxiesteróide desidrogenase tipo 5, composição farmacêutica, inibidor de 17ß-hidroxiesteróide desidrogenase tipo 5, processo para inibir 17ß-hidroxiesteróide desidrogenase tipo 3, inibidor de 17ß-hidroxiesteróide desidrogenase tipo 3, processos para tratar, ou reduzir o risco de desenvolver, câncer da próstata, hiperplasia prostática benigna, acne, seborréia, hirsutismo ou alopécia androgênica, sìndrome de ovário policìstico, câncer de mama, endometriose ou leiomioma, para inibir as secreções hormonais testiculares, para tratar puberdade precoce, e, kit
US6268356B1 (en) 1998-04-20 2001-07-31 Pharmaceutical Resources, Inc. Flocculated suspension of megestrol acetate
US6028065A (en) * 1998-04-20 2000-02-22 Pharmaceutical Resources, Inc. Flocculated suspension of megestrol acetate
US6656505B2 (en) 2000-07-21 2003-12-02 Alpharma Uspd Inc. Method for forming an aqueous flocculated suspension
US20030198679A1 (en) * 2000-11-08 2003-10-23 Kundu Subhas C. Flocculated pharmaceutical suspensions and methods for actives
CN106109435B (zh) * 2016-07-09 2018-11-06 南京臣功制药股份有限公司 一种醋酸甲地孕酮胶囊及其制备方法
CN106137993B (zh) * 2016-08-09 2018-11-09 南京臣功制药股份有限公司 一种醋酸甲地孕酮分散片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH236309A (de) * 1940-02-20 1945-01-31 Chem Ind Basel Verfahren zur Darstellung eines ,ss; , -zweifach ungesättigten Ketons.
US2311102A (en) * 1940-02-20 1943-02-16 Ciba Pharm Prod Inc Doubly unsaturated ketones and process of making same
US2900382A (en) * 1952-06-28 1959-08-18 Syntex Sa Method of making delta4,6 steroid compounds from delta4 steroid compounds
US2882282A (en) * 1957-07-17 1959-04-14 Pfizer & Co C Method of producing 3-keto-delta4, 6-steroid compounds from 3-keto a-ring saturated 6-dihydro steroid compounds
US2891079A (en) * 1959-01-23 1959-06-16 Searle & Co 6-methyl-4, 6-pregnadiene-3, 20-dione and 17alpha-acyloxy derivatives thereof

Also Published As

Publication number Publication date
US3356573A (en) 1967-12-05
FR1333711A (fr) 1963-08-02
MY6400075A (en) 1964-12-31
BE584312A (fr) 1960-05-04
GB870286A (en) 1961-06-14
DE1120446B (de) 1961-12-28
CH379493A (de) 1964-07-15

Similar Documents

Publication Publication Date Title
DE1072491B (fi)
FR970M (fi)
FR598M (fi)
AT214638B (fi)
IT598490B (fi)
FR78798E (fi)
AT217439B (fi)
FR464M (fi)
AT215747B (fi)
AT215751B (fi)
FR1194054A (fi)
AT216227B (fi)
AT213316B (fi)
AT213446B (fi)
AT213908B (fi)
AT213313B (fi)
AT216831B (fi)
AT213557B (fi)
AT216803B (fi)
AT213558B (fi)
AT216612B (fi)
AT213631B (fi)
AT213670B (fi)
AT216749B (fi)
AT213472B (fi)